- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 51.23M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 52.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 50.8M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $2.5M |
| Capex | Q1 2026 · Mar 31, 2025 | $300K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $35.2M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $17.9M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $50M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $43.6M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $553.5M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $534M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $140.2M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $126.3M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $595M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $603M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $219.2M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $205.6M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.18B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.17B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.36 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.35 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.37 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.35 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $96.7M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $107.5M |
| Net Income | Q1 2026 · Mar 31, 2026 | $19.2M |
| Net Income | Q1 2026 · Mar 31, 2025 | $17.8M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $29.3M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $15.9M |
| Revenue | Q1 2026 · Mar 31, 2026 | $264.8M |
| Revenue | Q1 2026 · Mar 31, 2025 | $259.9M |